Cargando…
Increasing diagnostic possibilities using the geneLEAD VIII platform for detection of SARS-CoV-2
At the time SARS-CoV-2 was identified as the cause of coronavirus disease 2019 (COVID-19) no in vitro diagnostic (IVD) tests were available since it was a new virus. Very shortly after the release of the genomic sequence of SARS-CoV-2, laboratory-developed tests (LDTs) were developed, made available...
Autores principales: | Boers, Stefan A., Mourik, Bas C., van Bussel, Mario J.A.W.M., de Brouwer, Caroline S., Wessels, Els, Claas, Eric C.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457920/ https://www.ncbi.nlm.nih.gov/pubmed/34562515 http://dx.doi.org/10.1016/j.jviromet.2021.114291 |
Ejemplares similares
-
A two minute liquid based sample preparation for rapid SARS-CoV2 real-time PCR screening: A multicentre evaluation
por: Claas, Eric C.J., et al.
Publicado: (2021) -
A Comprehensive Evaluation of GeneLEAD VIII DNA Platform Combined to Deeplex Myc-TB(®) Assay to Detect in 8 Days Drug Resistance to 13 Antituberculous Drugs and Transmission of Mycobacterium tuberculosis Complex Directly From Clinical Samples
por: Bonnet, Isabelle, et al.
Publicado: (2021) -
Detection of anti-feline infectious peritonitis virus activity of a Chinese
herb extract using geneLEAD VIII, a fully automated nucleic acid extraction/quantitative
PCR testing system
por: NISHIJIMA, Rui, et al.
Publicado: (2023) -
Comparison of the GeneFinder(TM) COVID-19 Plus RealAmp Kit on the sample-to-result Platform ELITe InGenius to the national reference method: An added value of N gene target detection?
por: Ong, David S.Y., et al.
Publicado: (2020) -
Performance of the QIAstat-Dx Gastrointestinal Panel for Diagnosing Infectious Gastroenteritis
por: Boers, Stefan A., et al.
Publicado: (2020)